Insider trade

Officer sold ~$149K of ELV shares in the open market

Traded Jun 12, 2026 · Filed Jun 15, 2026

Elevance HealthELV

~$149K
Reported value · 369 sh @ $403.16: 3,740
Holds after · shares reported: -5.5%
stock since the trade · S&P 500 +3.0%, $404.07 → $381.67 on Oct 1

Why it stands out

Elevance Health's CAO & Controller sold $149K of Elevance Health shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jun 12, 2026
Reporting period: Not applicable
Filed with the SEC: Jun 15, 2026

Officer$100K–$500K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$148,766

Shares × reported transaction price

Timing vs results

51 days after results of Apr 22, 2026, 33 days before results of Jul 15, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $404.07 on Jun 12, 2026, within 5% of its 52-week high, after a 7% rise over the previous 30 trading days

52-week range $274.66 (Aug 1, 2025) to $424.43 (Jun 9, 2026), 86% of the way up, from 251 adjusted closes. 30 trading days earlier: $376.42 on Apr 30, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on May 12, 2025 in the U.S. District Court, S.D. Indiana. A filing is an allegation, not a finding.

MILLER v. ELEVANCE HEALTH, INC., docket 1:25-cv-00923, via CourtListener (court records). Nature of suit 850, company named as first defendant

After it was reported

After	Stock	S&P 500	Difference
7 days	-0.7%	-2.2%	+1.6%
30 days	-6.3%	+0.1%	-6.3%
90 days	+6.7%	+1.4%	+5.2%

Past results only. Not a forecast.

Source receipt

Record ID: 0001659075-26-000006
Filed / recorded: Jun 15, 2026, 8:10 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: Elevance Health, Inc.
Issuer CIK: 1156039
Ticker: ELV
Reporting person: Ronald W Penczek
Relationship: Officer
Officer title: CAO & Controller
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Jun 12, 2026
Transaction code: S
Shares / units: 369
Price per share: $403.16
Acquired / disposed: Disposed (D)
Shares owned after: 3,740
Ownership form: Direct
Amendment: No

Footnotes from the filing

This transaction was executed in multiple trades at prices ranging from $403.15 to $403.31. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Around the same time

Director sold4mo ago

~$61KReported value · 151 sh @ $401.77

A board member of Elevance Health sold $61K of Elevance Health shares. Nobody planned it ahead of time.

Why it stands out Official record

5mo ago

654Shares · @ $271.27

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

5mo ago

877Shares · @ $311.48

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record